A case of topical 5-fluorouracil provoked psoriasis
Open Access
- 5 July 2023
- journal article
- case report
- Published by Elsevier in JAAD Case Reports
- Vol. 39, 30-33
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Drug-induced psoriasis: clinical perspectivesPsoriasis: Targets and Therapy, 2017
- BritishAssociation ofDermatologists' guidelines for the management of squamous cell carcinomain situ(Bowen's disease) 2014British Journal of Dermatology, 2014
- Treatment of Squamous Cell Carcinoma In Situ: A ReviewDermatologic Surgery, 2011
- Mechanisms of action of topical 5-fluorouracil: Review and implications for the treatment of dermatological disordersJournal of Dermatological Treatment, 2010
- Topical therapy for actinic keratoses, I: 5-Fluorouracil and imiquimod.2003
- Drug-Induced PsoriasisAmerican Journal of Clinical Dermatology, 2000
- Drugs in Exacerbation and Provocation of PsoriasisClinics in Dermatology, 1998
- "Psoriasis as a possible defect of the adenyl cyclase-cyclic AMP Cascade" by Voorhees and Duell, October 1971. Commentary: Cyclic adenosine monophosphate regulation of normal and psoriatic epidermisArchives of Dermatology, 1982
- Psoriasis as a Possible Defect of the Adenyl Cyclase-Cyclic AMP CascadeArchives of Dermatology, 1982
- Further Studies With Topical 5-FluorouracilArchives of Dermatology, 1965